Clinical Trial Update: Study of Letrozole in Recurrent Gliomas [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) study is investigating letrozole for recurrent gliomas (brain tumors). Recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: University of Cincinnati | Conditions: Brain Tumor | EARLY_Phase 1 | Status: RECRUITING